News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–11
Matches
11
Sources here
7
Companies here
1
Search results Stored financial headlines

Active search

11 matching headlines

Ticker or company: TVRDMain company stories
Clear

Tvardi Therapeutics (TVRD) plans up to $9.7M Nasdaq at-the-market stock offering

Tvardi Therapeutics (TVRD) is launching an at-the-market equity program to sell up to $9.7 million of common stock through JonesTrading. The proceeds are intended for general corporate purposes, including clinical trials, research and development, and potential in-licensing or acquisitions. This offering could result in …

TVRD main company
Sharemaestro market context Price below Trend Line 52 weeks -93.2% · Next-week setup negative 39.7% TVRD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Cara Therapeutics Inc. (CARA) Q1 2022 Earnings Call Transcript

Cara Therapeutics discussed its Q1 2022 financial results and commercial launch progress for KORSUVA injection in the U.S., highlighting initial positive reception and ordering by dialysis clinics. The company also announced the European approval of Kapruvia, triggering a $15 million milestone payment, and provided …

TVRD main company
Sharemaestro market context Price below Trend Line 52 weeks -93.2% · Next-week setup negative 39.7% TVRD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context